Exact Mass: 398.3032
Exact Mass Matches: 398.3032
Found 355 metabolites which its exact mass value is equals to given mass value 398.3032
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nandrolone cypionate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid
Lauroyl peroxide
D009676 - Noxae > D016877 - Oxidants > D010545 - Peroxides
Nb-Palmitoyltryptamine
Nb-Palmitoyltryptamine is found in alcoholic beverages. Nb-Palmitoyltryptamine is an alkaloid from seeds of Annona reticulata (custard apple) and Rollina mucosa (biriba). Alkaloid from seeds of Annona reticulata (custard apple) and Rollina mucosa (biriba). Nb-Palmitoyltryptamine is found in alcoholic beverages and fruits.
N-Stearoyl Asparagine
N-stearoyl asparagine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Stearic acid amide of Asparagine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Stearoyl Asparagine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Stearoyl Asparagine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
(2-Acetyloxy-3-hydroxypropyl) (E)-octadec-9-enoate
Tetracosanedioic acid
Tetracosanedioic acid, also known as tetracosanedioate, is a member of the class of compounds known as very long-chain fatty acids. Very long-chain fatty acids are fatty acids with an aliphatic tail that contains at least 22 carbon atoms. Thus, tetracosanedioic acid is considered to be a fatty acid lipid molecule. Tetracosanedioic acid is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Tetracosanedioic acid can be found in potato, which makes tetracosanedioic acid a potential biomarker for the consumption of this food product.
25,26,27-trinor-3alpha-hydroxy-17,14-frido-9beta-lanosta-7,14-dien-23-one
1,3,4,6-tetrahydroxy-1,2-epoxy-6-[10(Z)-heptadecenyl]cyclohexane
(3S,5Z,7E)-9,10-Secocholesta-5,7,10(19),23-tetraene-3,25-diol
3alpha-hydroxy-(20R)-25,26,27-trinor-8beta-lanosta-9(11),16-dien-24-one
3-Oxo-24,25,26,27-tetranortirucall-7-en-23,21-olide
3beta-3-Hydroxycholesta-5,25-dien-24-one|3beta-hydroxy-cholesta-5,25-dien-24-one
(2R*,4R*)-3,4-dihydro-4,5-dimethyl-8-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]-2H-[1]benzopyran-2,7-diol
(2E,6E,10E)-(+)-4beta-hydroxy-3-methyl-5beta-(3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl)cyclohex-2-en-1-one
(22E)-25,26,27-trinor-3beta-hydroxycycloart-22-en-24-al|(22E)-25,26,27-Trinor-3??-hydroxycycloart-22-en-24-al
(22E)-3beta-hydroxy-24-norcholesta-5,22-dien-7-one|(3beta,22E)-3-Hydroxycholesta-5,22-dien-7-one
3-heptadecadienyl-3,4-dihydro-8-hydroxyisocoumarin
(E)-1-[3-(4,8-dimethylnona-3,7-dienyl)cyclohex-3-enyl]-2,4,5-trimethoxybenzene
3-oxo-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone
A natural product found in Dysoxylum lenticellatum.
3-(hydroxymethyl)-1,14,15-trihydroxy-7,11,15-trimethyl-2,6,10-hexadecatrien-13-yl acetate
3-(hydroxymethyl)-1,13,15-trihydroxy-7,11,15-trimethyl-2,6,10-hexadecatrien-14yl acetate
(20R)-3-Oxo-24,25,26,27-tetranor-5alpha-cycloartan-23,21-olide|3-oxo-24,25,26,27-tetranor-5alpha-cycloartan-23,21-olide|aphagrandinoid D
1-(2,3-Dimethylphenethyl)-2-[2-methyl-4-(2,3-dimethylphenyl)butyl]-4-methylbenzene
5,9,13-trimethyl-eicos-5-en-17,18-diol-24-oic acid|anaphalisoic acid
(1S,3R,5Z,7E)-9,10-Secocholesta-5,7,10(19),24-tetraene-1,3-diol
(7E)-(1R,3R)-25,26-epoxy-19-nor-9,10-seco-5,7-cholestadien-23-yne-1,3-diol
(5Z,7E,22E,24E)-(1S,3R)-27-nor-9,10-seco-5,7,10(19),22,24-cholestapentaene-1,3,26-triol
(5Z,7E,22E)-(1S,3R)-9,10-seco-5,7,10(19),22-cholestatetraene-1,3-diol
(5Z,7E,22E)-(1R,3R)-9,10-seco-5,7,10(19),22-cholestatetraene-1,3-diol
(5Z,7E,22Z)-(1S,3R)-9,10-seco-5,7,10(19),22-cholestatetraene-1,3-diol
(5Z,7E,22Z)-(1R,3R)-9,10-seco-5,7,10(19),22-cholestatetraene-1,3-diol
1α-hydroxy-24,25-didehydrovitamin D3 / 1α-hydroxy-24,25-didehydrocholecalciferol
(5Z,7E)-(1S)-9,10-seco-5,7,10(19),9(11)-cholestatetraene-1,25-diol
25-hydroxy-16,17-didehydrovitamin D3 / 25-hydroxy-16,17-didehydrocholecalciferol
23,24-didehydro-25-hydroxyvitamin D3 / 23,24-didehydro-25-hydroxycholecalciferol
1-oxoprevitamin D3 / 1-oxoprecholecalciferol
Δ-6 Testosterone Enanthate
25,26-epoxy-1alpha-hydroxy-23,23,24,24-tetradehydro-19-norvitamin D3
(22E)-1alpha-hydroxy-22,23-didehydrovitamin D3
(22E)-1beta-hydroxy-22,23-didehydrovitamin D3
(22Z)-1alpha-hydroxy-22,23-didehydrovitamin D3
1alpha-hydroxy-24,25-didehydrovitamin D3 / 1alpha-hydroxy-24,25-didehydrocholecalciferol
25-hydroxy-16,17-didehydrovitamin D3
Pentagestrone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone
4-Pentylphenyl trans,trans-4-propyl-1,1-bicyclohexyl-4-carboxylate
butyl prop-2-enoate,2-ethylhexyl prop-2-enoate,2-methylprop-2-enoic acid
16-Doxyl-stearic acid methyl ester
Dimorpholamine
C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
trans-4-(4-propylcyclohexyl)phenyl trans-4-pentylcyclohexanecarboxylate
3-Oxo-24,25,26,27-tetrartirucall-7-en-23,21-olide
2,2,14,14-Tetramethyl-8-oxopentadecanedioic acid diethyl ester
25-hydroxy-16,17-didehydrovitamin D3/25-hydroxy-16,17-didehydrocholecalciferol
(2-Acetyloxy-3-hydroxypropyl) (E)-octadec-9-enoate
[3-carboxy-2-[(E)-hexadec-2-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(Z)-hexadec-9-enoyl]oxypropyl]-trimethylazanium
[(E)-2-(carboxymethyl)-2-hydroxy-3-oxooctadec-4-enyl]-trimethylazanium
[(2R)-3-carboxy-2-[(Z)-hexadec-9-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(9E,11E)-13-carboxytrideca-9,11-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(6E,9E)-13-carboxytrideca-6,9-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(2E,4E)-13-carboxytrideca-2,4-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-hexadec-11-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-hexadec-6-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-hexadec-4-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-hexadec-7-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(Z)-hexadec-7-enoyl]oxypropyl]-trimethylazanium
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(propan-2-ylcarbamoylamino)ethyl]oxan-3-yl]-3-piperidin-1-ylpropanamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[[oxo-(propan-2-ylamino)methyl]amino]ethyl]-3-oxanyl]-3-(1-piperidinyl)propanamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[[oxo-(propan-2-ylamino)methyl]amino]ethyl]-3-oxanyl]-3-(1-piperidinyl)propanamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-(propan-2-ylcarbamoylamino)ethyl]oxan-3-yl]-3-piperidin-1-ylpropanamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[[oxo-(propan-2-ylamino)methyl]amino]ethyl]-3-oxanyl]-3-(1-piperidinyl)propanamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[[oxo-(propan-2-ylamino)methyl]amino]ethyl]-3-oxanyl]-3-(1-piperidinyl)propanamide
N-[[(2S,3R,4R)-1-(cyclobutanecarbonyl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-N-ethylpropanamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[[oxo-(propan-2-ylamino)methyl]amino]ethyl]-3-oxanyl]-3-(1-piperidinyl)propanamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[[oxo-(propan-2-ylamino)methyl]amino]ethyl]-3-oxanyl]-3-(1-piperidinyl)propanamide
N-[[(2R,3R,4S)-1-acetyl-3-[4-(1-cyclopentenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-(2-methylpropyl)acetamide
N-[[(2R,3S,4S)-1-(cyclobutanecarbonyl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-N-ethylpropanamide
2-[[(2R)-3-decoxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[(1S)-3-carboxy-1-[(Z)-hexadec-9-enoyl]oxypropyl]-trimethylazanium
6-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]benzene-1,2,4-triol
[1-hydroxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] propanoate
[1-[(Z)-heptadec-9-enoxy]-3-hydroxypropan-2-yl] butanoate
[1-hydroxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] acetate
[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] pentanoate
[1-hydroxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] hexanoate
[1-hydroxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] octanoate
[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] heptanoate
(1-hydroxy-3-octoxypropan-2-yl) (Z)-tridec-9-enoate
12-Carboxymethyl-9-octadecenoic acid 1-(2-methoxyethyl) ester
(1-hydroxy-3-propanoyloxypropan-2-yl) (Z)-heptadec-9-enoate
(1-hydroxy-3-pentanoyloxypropan-2-yl) (Z)-pentadec-9-enoate
(1-hexanoyloxy-3-hydroxypropan-2-yl) (Z)-tetradec-9-enoate
(1-butanoyloxy-3-hydroxypropan-2-yl) (Z)-hexadec-9-enoate
(1-heptanoyloxy-3-hydroxypropan-2-yl) (Z)-tridec-9-enoate
2-[(3-Decoxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
all-trans-retinyl heptanoate
An all-trans-retinyl ester obtained by formal condensation of the carboxy group of heptanoic acid with the hydroxy group of all-trans-retinol.
solanidine(1+)
A tertiary ammonium ion resulting from the protonation of the tertiary amino group of solanidine. Major microspecies at pH 7.3.
9a,11a-dimethyl-1-(6-methylhept-5-en-2-ylidene)-2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthrene-5,7-diol
3,5b,8,8,11a,13a-hexamethyl-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h-chryseno[1,2-c]furan-1,13-dione
(4as,4br,6s,6ar,10as,10br,12as)-8-formyl-1,1,4a,6a,10b-pentamethyl-2,3,4,4b,5,6,10a,11,12,12a-decahydrochrysen-6-yl acetate
(4r,5r)-4-hydroxy-3-methyl-5-[(2e,6e,10e)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]cyclohex-2-en-1-one
[3-(1,2-dihydroxyethyl)-3-(hydroxymethyl)-4a,7,10a-trimethyl-octahydro-1h-naphtho[2,1-b]pyran-7-yl]methyl acetate
9a-(hydroxymethyl)-11a-methyl-1-(5-methyl-4-methylidenehex-1-en-1-yl)-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol
n-[(1s)-1-[(3as,3br,7r,9ar,9bs,11as)-7-(dimethylamino)-9a,11a-dimethyl-3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-n-methylacetamide
8,8,11a,13a-tetramethyl-1h,3h,5h,5ah,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-chryseno[1,2-c]furan-1-yl acetate
1-[(1r)-3-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]cyclohex-3-en-1-yl]-2,4,5-trimethoxybenzene
(1s,4r,5r,6r,10s,12s,13s,16r,21r)-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane-8,18-dione
(1r,3as,3bs,4r,7s,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r,3e)-6-methylhepta-3,5-dien-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol
1-(5-hydroxy-6-methylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
(4s,5s)-4-hydroxy-3-methyl-5-[(2e,6e,10e)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]cyclohex-2-en-1-one
10-dehydrohecogenin
{"Ingredient_id": "HBIN000103","Ingredient_name": "10-dehydrohecogenin","Alias": "NA","Ingredient_formula": "C26H38O3","Ingredient_Smile": "CC1CCC2(C(C3C(O2)CC4C3(C=CC5=C6CCC(CC6CCC45)O)C)C)OC1","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25946","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(22e)-25,26,27-trinor-3β-hydroxycycloart-22-en-24-al
{"Ingredient_id": "HBIN003724","Ingredient_name": "(22e)-25,26,27-trinor-3\u03b2-hydroxycycloart-22-en-24-al","Alias": "NA","Ingredient_formula": "C27H42O2","Ingredient_Smile": "CC(C=CC=O)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(C5(C)C)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21966","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}